By HIMSS TV | December 10, 2024 | 9:24 AM Precision medicine's genomic solutions were a great first step, but they are limited compared to AI's ability - for example, Artera's test for localized prostate cancer and recommended therapy, says CEO Andre Esteva. Topic: Patient Engagement, Operations, Digital Health, Artificial Intelligence